Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vaxil Bio Ltd (TSE:VXL)
TSXV:VXL
Holding TSE:VXL?
Track your performance easily
VXL Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week Range<C$0.01 - C$0.04
Previous CloseC$0.01
Volume4.43K
Average Volume (3M)117.28K
Market Cap
C$684.89K
Enterprise Value-C$235.10K
Total Cash (Recent Filing)C$920.00K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.14
Next Earnings
Aug 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding136,978,973
10 Day Avg. Volume0
30 Day Avg. Volume117,283
Standard Deviation0.63
R-Squared0.07
Alpha0.10
Financial Highlights & Ratios
Price to Book (P/B)1.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-7.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Vaxil Bio News
PremiumCompany Announcements
Vaxil Bio Announces Strategic Acquisition of Green Data Centers
PremiumCompany Announcements
Vaxil Bio Announces Potential Reverse Takeover
PremiumCompany Announcements
Vaxil Bio Advances Cancer Research Post-Takeover Termination
Options Prices
Currently, No data available
---
Ownership Overview
15.17%
Insiders
0.00% Mutual Funds
0.01% Other Institutional Investors
84.82% Public Companies and
Individual Investors
VXL FAQ
What was Vaxil Bio Ltd’s price range in the past 12 months?
Vaxil Bio Ltd lowest stock price was <C$0.01 and its highest was C$0.04 in the past 12 months.
What is Vaxil Bio Ltd’s market cap?
Currently, no data Available
When is Vaxil Bio Ltd’s upcoming earnings report date?
Vaxil Bio Ltd’s upcoming earnings report date is Aug 26, 2024 which is 92 days ago.
How were Vaxil Bio Ltd’s earnings last quarter?
Vaxil Bio Ltd released its earnings results on May 27, 2024. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
Is Vaxil Bio Ltd overvalued?
According to Wall Street analysts Vaxil Bio Ltd’s price is currently Overvalued.
Does Vaxil Bio Ltd pay dividends?
Vaxil Bio Ltd does not currently pay dividends.
What is Vaxil Bio Ltd’s EPS estimate?
Vaxil Bio Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vaxil Bio Ltd have?
Vaxil Bio Ltd has 136,978,970 shares outstanding.
What happened to Vaxil Bio Ltd’s price movement after its last earnings report?
Vaxil Bio Ltd reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Vaxil Bio Ltd?
Currently, no hedge funds are holding shares in TSE:VXL
---
Vaxil Bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-20.26%
Trailing 12-Months
Asset Growth
-31.55%
Trailing 12-Months
Company Description
Vaxil Bio Ltd
Vaxil Bio Ltd is an immuno-oncology biotechnology company. It is principally engaged in research and development of the ImMucin vaccine to treat cancer. ImMucin is the company's immunotherapy product. The organization is focused on developing novel immunotherapies including neoantigen-like peptide products, and antibodies to treat cancer and infectious diseases. Its VaxHit platform allows identification, isolation, and production of specific antigen-based immunotherapy products.
---
---